Catalyst Wire Dossier Catalyst Wire Dossier

Barhemsys

rolapitant · Helsinn Healthcare S.A.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Barhemsys, covering 2020-02-26 to 2024-09-26. Get the full timeline:

Most recent: Clinical Trial Update: A Pilot Study to Evaluate Barhemsys for the Prevention of Postoperative Nausea And Vomiting in the Bariatric Surgery Population [Phase 3]

See pricing